Speciality Medicines IPO Reservation
The Speciality Medicines IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 22,00,000 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
The Retail Individual Investor (RII) category has the highest allocation with 10,90,000 shares, representing 49.55% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 21,000 shares (0.95%), while Non-Institutional Investors (NIIs) receive 10,89,000 shares (49.5%). The NII portion is further divided into Big Non-Institutional Investors (BNII) with 7,26,000 shares (33%) and Small Non-Institutional Investors (SNII) with 3,63,000 shares (16.5%).
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 21000 | 0.95 | 0 |
| Non-Institutional | 1089000 | 49.5 | 0 |
| BNII | 726000 | 33 | 0 |
| SNII | 363000 | 16.5 | 0 |
| Retail Investors | 1090000 | 49.55 | 0 |
| Total | 2200000 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Speciality Medicines IPO?
The Retail Individual Investor (RII) quota in the Speciality Medicines IPO comprises 10,90,000 equity shares, representing 49.55% of the total IPO issue.
What is the reservation for QIBs in the Speciality Medicines IPO?
Qualified Institutional Buyers (QIBs) have been allocated 21,000 equity shares, representing 0.95% of the total IPO issue.
What is the reservation for HNI investors in the Speciality Medicines IPO?
The Non-Institutional Investors (NII) category has been allotted 10,89,000 equity shares (49.5%). This category is further divided into: Big HNI (bNII): 3,63,000 shares (33%) Small HNI (sNII): 7,26,000 shares (16.5%).
What is the category-wise reservation in the Speciality Medicines IPO?
The Speciality Medicines IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 21,000 shares (0.95%). Non-Institutional Investors (NII): 10,89,000 shares (49.5%). Retail Individual Investors (RII): 10,90,000 shares (49.55%).
Is there a shareholder quota in the Speciality Medicines IPO?
No. The Speciality Medicines IPO does not include a shareholder reservation.